PE20071083A1 - Derivados nuevos indolizina, su proceso de preparacion y las composiciones terapeuticas que las contienen - Google Patents
Derivados nuevos indolizina, su proceso de preparacion y las composiciones terapeuticas que las contienenInfo
- Publication number
- PE20071083A1 PE20071083A1 PE2006001477A PE2006001477A PE20071083A1 PE 20071083 A1 PE20071083 A1 PE 20071083A1 PE 2006001477 A PE2006001477 A PE 2006001477A PE 2006001477 A PE2006001477 A PE 2006001477A PE 20071083 A1 PE20071083 A1 PE 20071083A1
- Authority
- PE
- Peru
- Prior art keywords
- methanone
- propyl
- phenyl
- alkyl
- preparation process
- Prior art date
Links
- HOBCFUWDNJPFHB-UHFFFAOYSA-N indolizine Chemical class C1=CC=CN2C=CC=C21 HOBCFUWDNJPFHB-UHFFFAOYSA-N 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 206010002383 Angina Pectoris Diseases 0.000 abstract 1
- IFRNQHQAEISYJC-UHFFFAOYSA-N C(CC)N(CCCC1=CC=C(C=C1)C=O)CCC Chemical compound C(CC)N(CCCC1=CC=C(C=C1)C=O)CCC IFRNQHQAEISYJC-UHFFFAOYSA-N 0.000 abstract 1
- XQWDIPLTCUJPJQ-UHFFFAOYSA-N CCCN(CCC)CCCC1=CC=C(C=C1)C=O.Cl Chemical compound CCCN(CCC)CCCC1=CC=C(C=C1)C=O.Cl XQWDIPLTCUJPJQ-UHFFFAOYSA-N 0.000 abstract 1
- 206010019280 Heart failures Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 206010061216 Infarction Diseases 0.000 abstract 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 abstract 1
- OCBFFGCSTGGPSQ-UHFFFAOYSA-N [CH2]CC Chemical compound [CH2]CC OCBFFGCSTGGPSQ-UHFFFAOYSA-N 0.000 abstract 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
SE REFIERE A DERIVADOS DE INDOLIZINA DE FORMULA (I), EN DONDE X ES -(CH2)n SIENDO n UN NUMERO ENTERO DE 1 A 6, O UN GRUPO CH2-Z-8CH2)2-, DONDE Z ES O(CH2)m-, EN DONDE m ES UN NUMERO ENTERO DE 0 A 3; R1 ES ALQUILO(C1-C8) LINEAL, RAMIFICADO O CICLICO; Am ES NR3R4 EN DONDE R3 Y R4 SON IDENTICOS O DIFERENTES E INDEPENDIENTEMENTE SON H, ALQUILO(C1-C6), ENTRE OTROS; O JUNTOS AL N AL QUE ESTAN UNIDOS FORMAN UN HETEROCICLO DE 4 A 6 MIEMBROS CON HETEROATOMOS DE N Y O, OPCIONALMENTE SUSTITUIDOS; R2 ES H O ALQUILO(C1-C6). SON PREFERIDOS: CLORHIDRATO DE (2-BUTIL-6-ETILINDOLIZIN-3-IL){4-[3-(DIPROPILAMINO)PROPIL]FENIL}METANONA, OXALATO DE (2-ETILINDOLIZIN-3-IL){4-[3-(DIETILAMINO)PROPIL]FENIL}METANONA, CLORHIDRATO DE (2-BUTILINDOLIZIN-3-IL){4-[3-(DIPROPILAMINO)PROPIL]FENIL}METANONA, ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA Y UN PROCEDIMIENTO DE PREPARACION. ESTOS COMPUESTOS SON UTILES EN EL TRATAMIENTO DE LA ANGINA DE PECHO, HIPERTENSION, INSUFICIENCIA CARDIACA O PARA LA PREVENCION DE LA MORTALIDAD POST-INFARTO
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0511849A FR2893616B1 (fr) | 2005-11-23 | 2005-11-23 | Nouveaux derives d'indolizine, leur procede de preparation et les compositions therapeutiques les comprenant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20071083A1 true PE20071083A1 (es) | 2007-12-03 |
Family
ID=37027751
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2006001477A PE20071083A1 (es) | 2005-11-23 | 2006-11-20 | Derivados nuevos indolizina, su proceso de preparacion y las composiciones terapeuticas que las contienen |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US7799799B2 (es) |
| EP (1) | EP1957490B1 (es) |
| JP (1) | JP5372514B2 (es) |
| KR (1) | KR101419066B1 (es) |
| CN (1) | CN101312973B (es) |
| AR (1) | AR058208A1 (es) |
| AT (1) | ATE454386T1 (es) |
| AU (1) | AU2006316381B2 (es) |
| BR (1) | BRPI0618975A2 (es) |
| CA (1) | CA2629738C (es) |
| CR (1) | CR9927A (es) |
| CY (1) | CY1110623T1 (es) |
| DE (1) | DE602006011649D1 (es) |
| DK (1) | DK1957490T3 (es) |
| DO (1) | DOP2006000254A (es) |
| EA (1) | EA014158B1 (es) |
| EC (1) | ECSP088455A (es) |
| ES (1) | ES2338922T3 (es) |
| FR (1) | FR2893616B1 (es) |
| GT (1) | GT200600489A (es) |
| HR (1) | HRP20100158T1 (es) |
| IL (1) | IL190861A (es) |
| MA (1) | MA30055B1 (es) |
| NO (1) | NO20082589L (es) |
| PE (1) | PE20071083A1 (es) |
| PL (1) | PL1957490T3 (es) |
| PT (1) | PT1957490E (es) |
| SI (1) | SI1957490T1 (es) |
| TN (1) | TNSN08162A1 (es) |
| TW (1) | TW200738705A (es) |
| UY (1) | UY29965A1 (es) |
| WO (1) | WO2007060318A1 (es) |
| ZA (1) | ZA200803565B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2893616B1 (fr) | 2005-11-23 | 2008-01-04 | Sanofi Aventis Sa | Nouveaux derives d'indolizine, leur procede de preparation et les compositions therapeutiques les comprenant |
| FR2962438B1 (fr) | 2010-07-06 | 2012-08-17 | Sanofi Aventis | Derives d'indolizines, procedes de preparation et application en therapeutique |
| FR2962437B1 (fr) | 2010-07-06 | 2012-08-17 | Sanofi Aventis | Derives d'imidazopyridine, leur procede de preparation et leur application en therapeutique |
| CN103360390B (zh) * | 2013-07-23 | 2015-06-17 | 东南大学 | 中氮茚甲酰甲基对甲磺酰胺苯乙胺衍生物及其医药用途 |
| CN110156776A (zh) * | 2019-04-30 | 2019-08-23 | 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) | 一种c-3芳甲酰基吲嗪类化合物的制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI61030C (fi) * | 1976-02-19 | 1982-05-10 | Sanofi Sa | Foerfarande foer framstaellning av terapeutiskt verkande 2-substituerade-1- eller 3-benzoyl-indolizinderivat |
| FR2665444B1 (fr) | 1990-08-06 | 1992-11-27 | Sanofi Sa | Derives d'amino-benzofuranne, benzothiophene ou indole, leur procede de preparation ainsi que les compositions les contenant. |
| US5334716A (en) * | 1991-06-17 | 1994-08-02 | Fujisawa Pharmaceutical Co., Ltd. | Heterocyclic derivatives |
| US6593322B1 (en) * | 1999-03-17 | 2003-07-15 | Signal Pharmaceuticals, Inc. | Compounds and methods for modulation of estrogen receptors |
| FR2813306B1 (fr) * | 2000-08-23 | 2005-10-21 | Sanofi Synthelabo | Aminoalkybenzoyl-benzofurannes ou benzothiophenes, leur procede de preparation et les compositions les contenant |
| FR2893616B1 (fr) | 2005-11-23 | 2008-01-04 | Sanofi Aventis Sa | Nouveaux derives d'indolizine, leur procede de preparation et les compositions therapeutiques les comprenant |
-
2005
- 2005-11-23 FR FR0511849A patent/FR2893616B1/fr not_active Expired - Fee Related
-
2006
- 2006-11-15 DO DO2006000254A patent/DOP2006000254A/es unknown
- 2006-11-20 PE PE2006001477A patent/PE20071083A1/es not_active Application Discontinuation
- 2006-11-20 GT GT200600489A patent/GT200600489A/es unknown
- 2006-11-21 DK DK06831144.8T patent/DK1957490T3/da active
- 2006-11-21 BR BRPI0618975-0A patent/BRPI0618975A2/pt not_active IP Right Cessation
- 2006-11-21 EP EP06831144A patent/EP1957490B1/fr active Active
- 2006-11-21 ES ES06831144T patent/ES2338922T3/es active Active
- 2006-11-21 KR KR1020087012214A patent/KR101419066B1/ko not_active Expired - Fee Related
- 2006-11-21 AT AT06831144T patent/ATE454386T1/de active
- 2006-11-21 JP JP2008541787A patent/JP5372514B2/ja not_active Expired - Fee Related
- 2006-11-21 AU AU2006316381A patent/AU2006316381B2/en not_active Ceased
- 2006-11-21 PT PT06831144T patent/PT1957490E/pt unknown
- 2006-11-21 CN CN2006800437271A patent/CN101312973B/zh not_active Expired - Fee Related
- 2006-11-21 TW TW095143038A patent/TW200738705A/zh unknown
- 2006-11-21 AR ARP060105086A patent/AR058208A1/es not_active Application Discontinuation
- 2006-11-21 HR HR20100158T patent/HRP20100158T1/hr unknown
- 2006-11-21 CA CA2629738A patent/CA2629738C/fr not_active Expired - Fee Related
- 2006-11-21 ZA ZA200803565A patent/ZA200803565B/xx unknown
- 2006-11-21 DE DE602006011649T patent/DE602006011649D1/de active Active
- 2006-11-21 PL PL06831144T patent/PL1957490T3/pl unknown
- 2006-11-21 SI SI200630601T patent/SI1957490T1/sl unknown
- 2006-11-21 EA EA200801400A patent/EA014158B1/ru not_active IP Right Cessation
- 2006-11-21 WO PCT/FR2006/002551 patent/WO2007060318A1/fr not_active Ceased
- 2006-11-23 UY UY29965A patent/UY29965A1/es unknown
-
2008
- 2008-04-10 TN TNP2008000162A patent/TNSN08162A1/en unknown
- 2008-04-14 IL IL190861A patent/IL190861A/en not_active IP Right Cessation
- 2008-04-25 CR CR9927A patent/CR9927A/es not_active Application Discontinuation
- 2008-05-08 US US12/116,996 patent/US7799799B2/en not_active Expired - Fee Related
- 2008-05-16 EC EC2008008455A patent/ECSP088455A/es unknown
- 2008-06-10 NO NO20082589A patent/NO20082589L/no not_active Application Discontinuation
- 2008-06-16 MA MA31037A patent/MA30055B1/fr unknown
-
2010
- 2010-03-31 CY CY20101100303T patent/CY1110623T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20055568L (no) | Substituerte 1,4-diazepiner og anvendelser derav | |
| NI201000022A (es) | Nuevos derivados de 6-triazolopiridacina-sulfanil benzotiazol y bencimidazol, su procedimiento de preparación, su aplicación como medicamentos, composiciones farmacéuticas y nueva utilización principalmente como inhibidores de met. | |
| AR035617A1 (es) | Compuestos derivados de fenetanolamina, combinaciones y formulaciones farmaceuticas de los mismos, proceso para su preparacion, su uso en la preparacion de medicamentos para el tratamiento o profilaxis de una condicion clinica para la cual se indica un agonista beta2 adreno-receptor e intermediarios | |
| AR056873A1 (es) | Derivados de pirazolopirimidinas como inhibidores de quinasa dependientes de ciclina, composiciones farmaceuticas | |
| CY1113267T1 (el) | Παραγωγα θειοφαινιου ως αγωνιστες των υποδοσεων s1p1/edg1 | |
| PE20091562A1 (es) | Derivados de naftiridinona como inhibidores de cinasa y composiciones que los comprenden | |
| CY1106857T1 (el) | Βενζαμιδια 4-(αμινομεθυλ)-πιπεριδινης ως 5ht4-ανταγωνιστες | |
| EA200900279A1 (ru) | Арилсульфонамиды с аналгетическим действием | |
| PE20090620A1 (es) | Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen | |
| AR039601A1 (es) | Derivados de nitrosodifenilamina y composiciones farmaceuticas que los comprenden como medicamentos que se pueden utilizar en el tratamiento de patologias que se caracterizan por estres oxidativo | |
| CU23761B7 (es) | Nuevos derivados de diosmetina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| CL2011001093A1 (es) | Compuestos derivados de 4-[2-(2-fluorofenoximetil)fenil]piperidina, inhibidores de la recaptacion de serotonina y norepinefrina; procedimiento de preparacion; composicion farmaceutica que los comprende; y su uso para tratar el dolor neuropatico, fibromialgia, trastorno depresivo y obesidad entre otras. | |
| AR061835A1 (es) | Derivados tetraciclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| NI200900147A (es) | Nuevos derivados tricíclicos su procedimiento de preparación y las composiciones farmacéuticas que los contienen. | |
| EA200970124A1 (ru) | Производные 2-арилиндола в качестве ингибиторов npges-1 | |
| EA200600694A1 (ru) | Дисульфидные, сульфидные, сульфоксидные и сульфоновые производные циклических сахаров и их применение | |
| PE20080342A1 (es) | Inhibidores de proteasa de hiv de 2-(amino-sustituido)-benzotiazol sulfonamida | |
| PE20091018A1 (es) | Novedosos derivados de 1,3-dihidro-5-isobenzofurancarbonitrilo y composicion farmaceutica de los mismos para el tratamiento de la eyaculacion prematura | |
| CR9499A (es) | Nuevos derivados de fenilpiridinilpiperazina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| AR071619A1 (es) | Compuestos de pirazina fusionados utiles para el tratamiento de enfermedades degenerativas e inflamatorias y composiciones farmaceuticas que los contienen. | |
| AR056574A1 (es) | Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso | |
| AR058720A1 (es) | Derivados 2-feniletilamino y composicion farmaceutica | |
| PE20071083A1 (es) | Derivados nuevos indolizina, su proceso de preparacion y las composiciones terapeuticas que las contienen | |
| EA200101230A1 (ru) | Новые ингибиторы металлопротеаз, метод их получения и содержащие их фармацевтические композиции | |
| AR054747A1 (es) | Compuestos de indanil-piperazina un procedimiento para su preparacion y composiciones farmaceuticas que los contienen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |